logo
A pause in NIH funding leaves these Alzheimer's studies in limbo: ‘This is alarming'

A pause in NIH funding leaves these Alzheimer's studies in limbo: ‘This is alarming'

CNN24-04-2025

Zahydie Burgos Ribot and her husband, Francisco Rios, are checking items off their travel bucket list and spending quality time together before Francisco will no longer be able to travel – and before his brain forgets.
The Florida-based couple recently crossed Alaska off the list. Their next trip will be to Niagara Falls.
'We have a whole schedule,' Ribot said. 'We're choosing to live every single day with a lot of intention.'
That's because they know that Rios' window to easily create new memories is closing. About three years ago, at age 46, he was diagnosed with early-onset Alzheimer's disease.
Although Rios has been doing well on a new treatment he receives through a clinical trial, Ribot is increasingly afraid that the study could be hindered by cuts to federal funding of biomedical research.
The Trump administration has been conducting a restructuring of the US Department of Health and Human Services as well as a review of funding, resulting in the abrupt cancellation of hundreds of research grants under the National Institutes of Health and many others left in limbo, waiting for a decision on whether their funding will be renewed.
In March, 14 of 35 Alzheimer's Disease Research Centers had their funding halted by the NIH as the administration stopped $65 million in funding for research, according to Democratic lawmakers.
CNN has contacted HHS and the White House for comment.
'This is alarming, because these are critical data that inform not only prognosis but inform trajectory of the disease and inform future treatments,' Ribot said.
Rios also has been following these developments and remains worried about his future.
'He just asked me, 'Am I going to continue getting the trial?' But he was crying and literally ripping the skin off his fingers because of the anxiety,' Ribot said. 'He knows what's at stake. He is aware. He wants to continue the medication.'
Rios has been participating in a clinical trial conducted by Washington University in St. Louis in which he has been receiving the Alzheimer's drug Leqembi paired with an experimental therapy called E2814, given as intravenous infusions, to help slow his Alzheimer's symptoms.
Ribot credits the trial with helping curb Rios' memory loss and cognitive decline.
Before Rios was diagnosed, he began to emotionally withdraw and disconnect from loved ones. He even got lost while driving to a routine doctor's appointment about 10 minutes from their home, Ribot said.
She initially thought he was showing signs of depression. But Rios' doctor realized that something else was happening in his brain and referred him to the Young-Onset Dementias Clinic at Johns Hopkins in Baltimore.
'They ran more tests, and they ran the genetic testing, and that's when we had the final confirmation that it was Alzheimer's,' Ribot said.
If funding for Rios' clinical trial is curtailed, she said, not only could he and the other participants lose access to the medications that they hope are giving them more time to live normally, the development of other impactful Alzheimer's treatments could be delayed.
About a dozen Alzheimer's disease research centers are still waiting for their federal funding to be renewed, said Dr. Michael Greicius, professor of neurology and neurological sciences at the Stanford University School of Medicine, whose Alzheimer's center is among those awaiting a decision.
'Our five-year renewal was reviewed in October. Normally, we would have gotten a decision probably around February,' he said, adding that research funding for his team at the Stanford Alzheimer's Disease Research Center ran out about three weeks ago.
'It seems like we're moving towards renewal, but it's very hard to read the tea leaves, and that makes it really challenging when you're thinking about projects you'd like to undertake or hiring new research coordinators, for example,' he said.
Greicius and his colleagues had to hold off on starting research projects because they didn't know whether there will be funding coming in, he said.
The uncertainty around funding baffles him.
'It's hard to imagine a less political topic than Alzheimer's disease. I mean, it affects people from red states and blue states and purple states. It's so common. Almost everyone either has a relative in their family or at least has a friend who has a relative that's been affected by Alzheimer's disease,' Greicius said.
'It still seems like the easiest-to-agree-upon target for federally funded research, and yet it's not at all clear that this progress is going to continue,' he said. 'That, for me, is a large part of the frustration – just the uncertainty of it all.'
Preventive neurologist Dr. Richard Isaacson, founder of one of the first Alzheimer's prevention clinics in the United States, is also waiting to see whether his federal grants will be renewed.
'We're somewhere between limbo and purgatory,' he said.
Isaacson, who directs research at the Institute for Neurodegenerative Diseases in Florida, has developed free online software called RetainYourBrain, which aims to democratize access to brain health care. Users input their risk factors for Alzheimer's and receive a personalized risk assessment, as well as personalized recommendations and time-sensitive reminders on how to improve their brain health.
But without continued funding, 'it may never be released to the public,' Isaacson said.
Supporters of the funding cuts argue that the nation should reduce 'wasteful spending' and prioritize efficiency.
'With the government wanting to cut back on spending money, I get it. But Alzheimer's is one of the most expensive diseases to our health care system,' Isaacson said.
It's estimated that nearly 1 in every 6 Medicare dollars was spent on someone with the disease last year, according to the Alzheimer's Association, and the average per-person Medicare spending for older adults with Alzheimer's is estimated to be 2.8 times higher than average per-person spending for all other seniors.
'I feel that cutting Alzheimer's research that may save money over time, and doing it rapidly, is a bad investment,' Isaacson said.
While some studies are waiting to see if they'll continue, some studies have already had to take steps to shut down.
When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer's studies were swept up in the consequences.
Federal funding for a multiyear study at the University of California, Davis' Alzheimer's Disease Research Center was abruptly terminated. This led the center's co-director, Dr. Charles DeCarli, to issue an appeal and fight to have the grant fully reinstated.
'The appeal had to be done within 30 days, and in the meantime, we had to shut down the study. So while I was working on the appeal, my team was doing all the things that closing a study needs to involve, which is hundreds of hours of work, notifying the 33 sites in this study,' he said.
DeCarli's appeal was successful. He won that battle but is still recovering from the turmoil.
'It was a very challenging month in my life,' DeCarli said. 'It just seems to me that the only reason that this was terminated is because it includes the word 'diverse' in the title.'
The study, titled 'The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED),' involves examining the effect that white matter injury in the brain and vascular issues may have on cognitive performance as well as health outcomes. The research was being funded by the NIH's National Institute of Neurological Disorders and Stroke.
Up to 25% of people who develop dementia later in life may have some type of vascular contributing factor to their disease, and DeCarli said his study could help 'lay out the foundation' for diagnostic tests and treatments for them.
'When these studies are terminated, an opportunity is lost to advance science,' he said.
Other studies may face similar threats to funding. According to a policy notice issued Monday, the NIH said it will begin pulling medical research funding from universities with diversity and inclusion programs and any boycotts of Israeli companies.
The agency 'reserves the right to terminate financial assistance awards and recover all funds' if grant recipients do not comply with federal guidelines barring diversity and equity research and 'prohibited boycotts,' the notice said.
The policy applies to 'domestic recipients of new, renewal, supplement, or continuation awards that are issued on or after' April 21, according to the notice.
Separately, the Washington-based nonprofit UsAgainstAlzheimer's has been tracking previously terminated grants and the funding cuts at the NIH that took place in March and earlier this month, and it warns that some cuts could stall the progress being made to find a cure for Alzheimer's disease.
'In the last 10 years, there have been groundbreaking advances in Alzheimer's disease research, in understanding where the disease comes from, and understanding how to diagnose the disease, and ultimately in how to treat the disease. But we don't have a cure yet,' said Russ Paulsen, chief operating officer at UsAgainstAlzheimer's.
'In looking through the list of grants that have been affected, it appears to cut across prevention, diagnosis, treatment and ultimately seeking a cure, as well as understanding the basics of the disease to start with,' he said. 'We've made huge progress, and now is not the time to take our foot off the accelerator.'
In the meantime, Ribot and Rios are trying to keep their heads up. They are keeping an eye on any new developments in research funding cuts while continuing to focus on their travel bucket list.
'While he's here and we're here, we're living our life. We are finding joy. Even when we cry, we laugh. Even when we are in despair, we have hope,' Ribot said.
'I'm not going to romanticize this disease, because that's not it – but there's still purpose and meaning and joy,' she said. 'We're not going to let this disease rob us of our present.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The CDC says guns are the No. 1 killer of children. Here's what's really true
The CDC says guns are the No. 1 killer of children. Here's what's really true

Miami Herald

time2 hours ago

  • Miami Herald

The CDC says guns are the No. 1 killer of children. Here's what's really true

With Robert F. Kennedy's Make Children Healthy Again report under attack for questionable science, imaginary research and other 'formatting errors,' as the White House calls them, Democrats are worrying about a politicized public health system selling snake oil to the American public. You don't have to look far back in time for examples of the government public health system and the private sector experts who influence it and spearhead its research efforts selling snake oil. The coronavirus pandemic was rife with them. There was the time public health officials simply made up the claim that staying 6 feet apart would help stop the spread of COVID-19. And the time top officials and scientists conspired to falsely 'debunk' concerns that the coronavirus was released from a Chinese lab. And then there were times when public health advice was politicized, like when public health officials said gathering in groups was unsafe, except if it was to protest the death of George Floyd. They're not just about COVID, either. Remember the great kerfuffle over Flint, Michigan's lead problem? The people who were telling you that Black kids were poisoned forgot to tell you that there own data showed blood lead levels of lead in 'poisoned' kids were much lower than just a decade earlier when nobody was talking about poisoned kids. This weekend, you'll be treated to another misinformation campaign that comes with the imprimatur of the Centers for Disease Control and Prevention and the National Institutes of Health. It's time for the annual 'Gun Violence Awareness Week.' This weekend, buildings all over the country will light up orange in solidarity with those who have lost their lives in what has become a daily bloodbath we spend most of the year ignoring. Among the claims you'll be hearing is one I received from a local Kansas City backer of Moms Demand Action, a gun control group. 'Gun deaths are the number one cause of deaths of American children and adolescents,' her email said. Others say the facts are even more stark. California Gov. Gavin Newsom took out ads on social media saying, 'Guns are the number one killer of kids.' In a speech to mayors, Vice President Kamala Harris said, 'Gun violence is the leading cause of death of the children of America — leading cause of death — not car accidents, not some form of cancer — gun violence.' Facts trigger truth The facts tell a different story. Guns are not the number one killer of children at any age between 0 and 12. They never have been. Cars are the biggest killer. Who says? The CDC database called WONDER that tracks the cause of death in most U.S. deaths indexed by race, sex and age among other characteristics. For a number of kids' years of life, drowning or falls are a greater threat than guns. I asked the Kansas City activist who sent that claim to me why she was spreading such a lie. She didn't respond, but the national press person for Everytown for Gun Safety did reply, citing the CDC and the National Institute of Health as her sources. She sent links. And she's right. Here's what the CDC says: 'Taking into account all types of firearm injuries, including homicides, suicides, and unintentional injuries, firearm injuries were the leading cause of death among children and teens ages one to 19 in 2020 and 2021.' What they mean is if you lump all the dead children and teens in one pile and count how they died, for the whole gruesome pile, the No. 1 killer was guns. But that is only because guns kill so many teens — a large number of them 18- and 19-year-old adult teens. It has nothing to do with children's deaths. Elsewhere on its website, the CDC admits this difference, giving the cause of death for different groups of children as 'accidents.' Why would the CDC do something so misleading? Well, it goes back many decades in which reporting what the leading killer of children and teens was made perfect sense. The killer was the same for them all — accidents, mostly car accidents. So naturally, they reported the number all together. When guns overtook car accidents during the Biden administration, they just kept doing the same thing they had always done. Gun control groups loved it because that let them make the claim that children were dying left and right from guns. That scared concerned parents into backing their agenda and coughing up donations. The Biden administration CDC didn't seem to mind. But there's more to this story that is misleading. Remember guns are the No. 1 killer of teens, but are guns a threat to your kids? Probably not. Which teens? The CDC's WONDER(ful) database reveals that: Guns are not the number one killer of female are not the number one killer of white are not the number one killer of Hispanic are not the number one killer of Asian are not the number one killer of Native American only group for whom this claim is true is Black teens, which is statistically troubling in itself. It isn't like these facts are a shock. I found many of them in the Journal of the American Medical Association. But they do reveal the politicization of our public health experts. When I asked the author of the article, Dr. Elizabeth Wolf, about the gun control groups' claim and the fact that it wasn't actually true that children, female teens, white teens, Hispanic teens, Asian teens and Native American teens were so threatened by guns, she replied that the claim is perfectly accurate and then stopped responding to my emails. That's nuts. So if there is an annual bloodbath of gun violence in the United States, why does the slicing and dicing of dry statistics matter? If your goal is to raise campaign donations and build a national political movement to restrict gun rights, it doesn't matter. Scaring parents whose kids are not at much risk by fudging the issue works great. If your goal is to get Congress to fork over millions in research grants on the problem of gun violence, it works great to make Congress think the bullets are flying everywhere and that the blood is flowing on rural, suburban and urban congressional district streets alike. But if your goal is to actually solve the problem, well, then it really does matter just who is dying and why. Only when we face the answer to that question can we focus resources where the problem is and come up with ways to do something about it. It would be nice if the CDC made that a priority.

Onslow County Public Library in Swansboro to host Alzheimer's event
Onslow County Public Library in Swansboro to host Alzheimer's event

Yahoo

time2 hours ago

  • Yahoo

Onslow County Public Library in Swansboro to host Alzheimer's event

SWANSBORO, N.C. (WNCT) — The Onslow County Public Library-Swansboro and Onslow County Cooperative Extension are teaming up with the Alzheimer's Association – Eastern North Carolina Chapter to host a free Alzheimer's program. This program is called Healthy Living for your Brain and Body, and it will be on June 27, from 10am-11:30am at the Onslow County Public Library in Swansboro. At this event, you will get to learn how certain modifiable risk factors and health behaviors can help reduce the risk of cognitive decline. There will also be a cooking demonstration and tasting from the Onslow NC Cooperative Extension program MED instead of MEDs, which was designed to address healthy eating and educate attendees on how eating a Mediterranean diet can help protect them from chronic illnesses and potentially decrease the need for medications. 'The brain changes that cause Alzheimer's are thought to begin 20 years or more before symptoms start, which suggests that there may be a substantial window of time in which to intervene in the progression of the disease,' Executive Director, Alzheimer's Association – Eastern North Carolina Chapter, Christine John-Fuller, said. 'June is Alzheimer's and Brain Awareness Month, and this is a great opportunity to learn how you can strengthen brain health and reduce your risk for the disease.' This program is free and open to the general public. To learn more and register, click here or call 800-272-3900. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Texas to expand psychedelic research with $50M ibogaine investment
Texas to expand psychedelic research with $50M ibogaine investment

Yahoo

time2 hours ago

  • Yahoo

Texas to expand psychedelic research with $50M ibogaine investment

AUSTIN (KXAN) — Texas Gov. Greg Abbott is holding a bill signing ceremony Tuesday for legislation that invests $50 million into clinical research of ibogaine — a naturally occurring psychedelic substance that could treat post-traumatic stress disorder, opioid use disorder and other mental health conditions. For years, veterans and others suffering from PTSD have sought ibogaine treatment in Mexico, where the substance is not heavily regulated. In the United States, ibogaine is classified as a Schedule 1 drug, the most restrictive drug category. Other drugs classified under Schedule 1 include psilocybin, LSD and heroin. According to the legislative summary of SB 2308, the implications for those with opioid use disorder are lifechanging; a single administration of ibogaine in a controlled setting has been shown to stop withdrawal symptoms and reduce drug cravings long-term. RELATED: Lawmakers hope to expand medical marijuana program as state bans intoxicating hemp products 'Preliminary reports also suggest benefits in cognitive function, mood regulation, and sleep among individuals with [traumatic brain injury] and PTSD—conditions prevalent among U.S. veterans,' the bill text read. The new legislation will create a program within the Texas Health and Human Services Commission to support Texas-based trials of ibogaine through the FDA. Ibogaine is not currently FDA-approved due to its Schedule 1 classification. SB 2308 will fund research through gifts, grants or donations and will require equal matching funds by the recipients, which will include Texas medical facilities 'equipped for cardiac-intensive monitoring' by a supervising physician, among other qualifications. 'By advancing ibogaine research, Texas has the opportunity to lead in neuroscience innovation, address urgent veteran health needs, and shape the future of mental health treatment nationwide,' the bill text reads. While legislation aimed at easing access to ibogaine moves forward, separate legislation to restrict access to another plant has also progressed. Texas lawmakers sent a bill banning non-medical THC products to Abbott for approval late last month. Still, Texas in recent years has become more open-minded to the use of psychedelic substances in treating mental health conditions. 'There's definitely been a shift in the openness and the receptivity of the field to this type of research,' said Greg Fonzo, Ph.D., co-director of the McGill Center for Psychedelic Research & Therapy at Dell Medical School. 'People who do undergo this treatment process, some of them respond well and have a benefit in terms of symptom reductions and feeling better,' Fonzo told KXAN earlier this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store